Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $23.7100 (0.38%) ($23.2000 - $23.9000) on Thu. Feb. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.03% (three month average) | RSI | 62 | Latest Price | $23.7100(0.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) ARKG(48%) XBI(48%) IWO(44%) ARKK(43%) | Factors Impacting IOVA price | IOVA will decline at least -1.515% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.515% (StdDev 3.03%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $23.38(1.41%) | 10 Day Moving Average | $23.22(2.11%) | 20 Day Moving Average | $23.01(3.04%) | To recent high | -19.4% | To recent low | 9.6% | Market Cap | $3.472b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |